Advanced Endoscopy During COVID-19
The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study
The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study
Sponsor study identifier
observational
670
5 countries
5
Study Start
May 18, 2020
Actual (reported)Primary Completion
July 1, 2020
Actual (reported)Study Completion
July 5, 2020
Actual (reported)In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 5, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 11, 2020
Actual (reported)May 12, 2020
Actual (reported)May 18, 2020
Actual (reported)July 1, 2020
Actual (reported)July 5, 2020
Actual (reported)Age, gender, nationality
Investigators will report the baseline demographic data (age, gender, nationality) of all patients.
3 months
Indication for procedure, status of SARS-CoV-2 infection
Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.
3 months
Complete blood count and liver functions tests
Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.
3 months
Patients who will have endoscopic retrograde cholangiopancreatography
Patients who will have endoscopic ultrasound
Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All patients with digestive disorders referred for ERCP or EUS during the study period in the participating centers
Kings County Hospital Center, Brooklyn, NY, USA
Albertson, New York, 11507, United States
Al-Azhar Univerisity
Cairo, 11651, Egypt
University Medicine Greifswald
Greifswald, D-17475, Germany
2- Hospital Guillermo Kaelin De la Fuente - EsSalud
Lima, Peru
Singapore General Hospital
Singapore, 169856, Singapore
670 participants (actual enrollment reported by the registry).
First Submitted
May 11, 2020
First Posted
May 12, 2020
Study Start
May 18, 2020
Actual (reported)A Study of the Effectiveness of Moderna COVID-19 Vaccine
procedure related complications
Investigators will report the procedure related complications.
3 months
Effect of COVID-19 precautions on procedure time
3 months
Effect of COVID-19 precautions on staff number
3 months
Contact the study team to confirm eligibility.
Primary Completion
July 1, 2020
Actual (reported)Study Completion
July 5, 2020
Actual (reported)Last Updated
July 8, 2020
Record last verified: 2020-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: